Jennifer Cassels
Blood Cancer UK(GB)University of Glasgow(GB)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Epigenetics and DNA Methylation, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Ubiquitin and proteasome pathways
Most-Cited Works
- → Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition(2016)132 cited
- → CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression(2016)73 cited
- → CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy(2020)68 cited
- → Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells(2024)14 cited
- → CD93 Is a Novel Biomarker of Leukemia Stem Cells in Chronic Myeloid Leukemia(2015)11 cited
- → mTORC1 activity is essential for erythropoiesis and B cell lineage commitment(2019)11 cited
- → mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia(2023)9 cited
- → The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos Syndrome(2025)8 cited
- → BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia(2022)7 cited
- → PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling(2022)4 cited